The Istituto Nazionale Tumori IRCCS Fondazione G. Pascale in Naples is leading Elena-Care, an international research and care project on hereditary breast cancer, according to Il Mattino.
The network involves partners in Italy, Switzerland, Romania and Greece. The project is coordinated by the Pascale Institute in Naples.
Elena-Care targets people with a possible hereditary predisposition to breast cancer. It also addresses hereditary male breast cancer.
Its proposed pathway links hereditary-risk assessment, oncogenetic counseling, genetic testing, and personalized surveillance and prevention. The project was conceived by oncologist Matilde Pensabene, according to Mondosanita.
A hereditary predisposition is not equivalent to a cancer diagnosis. Its implications depend on the gene, the variant and the individual or family context.
Genetic information can affect both prevention and treatment decisions. That includes the possible assessment of targeted therapies in selected BRCA-associated breast cancers.
The project seeks to reduce barriers to care including geographic distance, financial constraints, cultural barriers and limited digital or health literacy. A planned digital application is intended to improve access to services and support health and digital literacy.
Elena-Care is part of the European THCS partnership and is co-financed by Horizon Europe. It has a reported total value of approximately €1.48 million and a duration of 36 months.
The Italian Ministry of Health allocation described for the project is €400,000. That includes €250,000 for Pascale and €150,000 for the Istituto Europeo di Oncologia in Milan.
The project fits Pascale's broader institutional role in European oncology research. The institute's official profile describes it as a public IRCCS combining clinical and experimental oncology research with complex cancer care, including a major focus on breast disease.



